Characteristics of gastric cancers developed more than 10 years after eradication of Helicobacter pylori

被引:0
作者
Sasaki, Akiko [1 ]
Ichita, Chikamasa [1 ]
Sumida, Chihiro [1 ]
Nishino, Takashi [1 ]
Nagayama, Miki [1 ]
Kawachi, Jun [2 ]
Suno, Yuma [2 ]
Murata, Takaaki [2 ]
Naito, Wataru [3 ]
Yamamichi, Nobutake [4 ]
机构
[1] Shonan Kamakura Gen Hosp, Med Ctr, Dept Gastroenterol, 1370-1 Okamoto, Kamakura, Kanagawa 2478533, Japan
[2] Shonan Kamakura Gen Hosp, Dept Gen Surg, Kamakura, Kanagawa, Japan
[3] Shonan Kamakura Gen Hosp, Dept Diagnost Pathol, Kamakura, Kanagawa, Japan
[4] Univ Tokyo, Ctr Epidemiol & Prevent Med, Grad Sch Med, Tokyo, Japan
关键词
chronic inflammation; eradication; gastric cancer; Helicobacter pylori; surveillance interval; DNA METHYLATION; THERAPY; INFECTION; CARCINOMA; SURFACE; RISK;
D O I
10.1097/MD.0000000000040492
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Helicobacter pylori (H pylori) eradication is expected to effectively prevent gastric cancer (GC). However, GC cases may occur even longer than 10 years after H pylori eradication (L10AE). Moreover, the associated factors and characteristics are unknown. In this retrospective, single-center study conducted between 2017 and 2022, patients with GC diagnosed after H pylori eradication were enrolled and categorized into groups according to whether they were shorter than 10 years after H pylori eradication (S10AE) or L10AE. Patients were also categorized according to the depth of cancer invasion. Clinical data, pathological data, and risk factors were analyzed using logistic regression. Clinicopathological characteristics of GC diagnosed at L10AE and those invading the submucosal tissue or deeper (SMD) were investigated. In total, 202 cases of GC occurring after H pylori eradication were identified. Comparison of 158 S10AE and 44 L10AE GC cases revealed a significantly longer surveillance interval (SI) in L10AE cases (median: 2.0 vs 1.0 years, P = .01). Comparison of 150 intramucosal and 52 SMD GC cases revealed that L10AE GC cases were significantly more frequent amongst the SMD cases (18.0% vs 32.7%, P = .03). Pathologically, undifferentiated and mixed types were significantly more frequent in GC cases with SMD invasion (P < .001). Multivariate analysis revealed that L10AE was significantly related to GC cases with SMD invasion (odds ratio, 2.45; 95% confidence interval, 1.15-5.11; P = .019). SI was significantly longer in GC that developed at L10AE than at S10AE. In addition, GC with SMD invasion was more frequently detected in L10AE than in S10AE. Our data indicated that SI should not be groundlessly extended in patients at L10AE.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Gastric Cancer Development after Helicobacter pylori Eradication Therapy: A New Form of Gastric Neoplasia
    Matsuo, Taiji
    Ito, Masanori
    Tatsugami, Masana
    Boda, Tomoyuki
    Takata, Shunsuke
    Tanaka, Shinji
    Chayama, Kazuaki
    DIGESTION, 2012, 85 (01) : 61 - 67
  • [32] A case of nodular gastritis progression to autoimmune gastritis after 10 years of Helicobacter pylori eradication
    Sumi, Naoki
    Haruma, Ken
    Inoue, Kazuhiko
    Hisamoto, Nobumi
    Mabe, Katsuhiro
    Sasai, Takako
    Ichiba, Toshio
    Ayaki, Maki
    Manabe, Noriaki
    Takao, Toshihiro
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (02) : 216 - 221
  • [33] Effect of Helicobacter pylori Eradication and ABO Genotype on Gastric Cancer Development
    Oh, Sooyeon
    Kim, Nayoung
    Kwon, Jin-Won
    Shin, Cheol Min
    Choi, Yoon Jin
    Lee, Dong Ho
    Jung, Hyun Chae
    HELICOBACTER, 2016, 21 (06) : 596 - 605
  • [34] Eradication of Helicobacter pylori and Gastric Cancer: A Controversial Relationship
    Piscione, Mariagrazia
    Mazzone, Mariangela
    Di Marcantonio, Maria Carmela
    Muraro, Raffaella
    Mincione, Gabriella
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [35] Characteristics of Primary and Metachronous Gastric Cancers Discovered after Helicobacter pylori Eradication: A Multicenter Propensity Score Matched Study
    Maehata, Yuji
    Nakamura, Shotaro
    Esakil, Motohiro
    Ikeda, Fumie
    Moriyama, Tomohiko
    Hida, Risa
    Washio, Ema
    Umenol, Junji
    Hirahashi, Minako
    Kitazonol, Takanari
    Matsumoto, Takayuki
    GUT AND LIVER, 2017, 11 (05) : 628 - 634
  • [36] Epstein-Barr virus-associated gastric carcinomas developed after successful eradication of Helicobacter pylori
    Nishikawa, Jun
    Shuto, Takuya
    Yanagi, Ayaka
    Takagi, Tatsuya
    Ogawa, Ryo
    Sasaki, Sho
    Goto, Atsushi
    Hamabe, Kouichi
    Hashimoto, Shinichi
    Okamoto, Takeshi
    Sakaida, Isao
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2020, 13 (04) : 506 - 511
  • [37] Long-term endoscopic gastric mucosal changes up to 20 years after Helicobacter pylori eradication therapy
    Iwata, Eri
    Sugimoto, Mitsushige
    Akimoto, Yoshika
    Hamada, Mariko
    Niikura, Ryota
    Nagata, Naoyoshi
    Yanagisawa, Kyosuke
    Itoi, Takao
    Kawai, Takashi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [38] Gastric cancer detected after Helicobacter pylori eradication
    Tashiro, Jun
    Miwa, Jun
    Tomita, Takashige
    Matsubara, Yasuo
    Oota, Yasuhiko
    DIGESTIVE ENDOSCOPY, 2007, 19 (04) : 167 - 173
  • [39] Second Cancers and Residual Disease in Patients Treated for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Helicobacter pylori Eradication and Followed for 10 Years
    Wuendisch, Thomas
    Dieckhoff, Philipp
    Greene, Brandon
    Thiede, Christian
    Wilhelm, Christian
    Stolte, Manfred
    Neubauer, Andreas
    GASTROENTEROLOGY, 2012, 143 (04) : 936 - 942
  • [40] Helicobacter pylori recurrence after eradication in Latin America: Implications for gastric cancer prevention
    Corral, Juan E.
    Mera, Robertino
    Dye, Corey W.
    Morgan, Douglas R.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 9 (04) : 184 - 193